Right heart condition in patients with COVID-19 pneumonia

Right heart condition in patients with COVID-19 pneumonia

Aim. To assess right heart condition in patients with coronavirus disease 2019 (COVID-19) pneumonia.Material and methods. One hundred and five patients with COVID-19 pneumonia were divided into 3 groups depending on the involvement of lung parenchyma: group I — 0-25%, II — 25-50%, III — 50-75%. The...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. G. Poteshkina, N. S. Krylova, A. A. Karasev, T. A. Nikitina, A. M. Svanadze, I. P. Beloglazova, E. A. Kovalevskaya, K. A. Barakhanov, M. A. Lysenko, A. M. Ibragimova, V. N. Smorshchok
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2021-12-01
Series:	Российский кардиологический журнал
Subjects:	covid-19 echocardiography nt-probnp right heart global longitudinal strain
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4733
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dynamics of global and segmental strain as a marker of right ventricular contractility recovery in patients after COVID-19 pneumonia
by: N. E. Shirokov, et al.
Published: (2023-02-01)

Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered questions
by: E. A. Lyasnikova, et al.
Published: (2021-07-01)

Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia
by: H.M. Kim, et al.
Published: (2020-08-01)

HEART FAILURE IN SYSTEMIC LUPUS ERYTHEMATOSUS: RISK FACTORS AND DIAGNOSTIC FEATURES
by: T. A. Panafidina, et al.
Published: (2018-07-01)

N-TERMINAL PROHORMONE OF BRAIN NATRIURETIC PEPTIDE IN THE DIAGNOSIS AND MANAGEMENT OF PERSISTENT PULMONARY HYPERTENSION IN NEWBORNS
by: Sinan Tüfekci, et al.
Published: (2022-03-01)

Changes of biventricular contractile function depending on the types of left ventricular involvement in patients 1 year after COVID-19 pneumonia
by: N. E. Shirokov, et al.
Published: (2024-03-01)

Characteristics of patients with chronic heart failure in different age groups
by: R. I. Jafarov, et al.
Published: (2023-05-01)

Level and correlations of soluble suppression of tumorigenicity 2 protein in heart failure and its relationship with clinical and paraclinical characteristics of patients
by: A. Ya. Kravchenko, et al.
Published: (2022-06-01)

PREDICTORS OF CONTINUOUS HOSPITAL STAY IN ADULT PATIENTS WITH ACQUIRED VALVULAR DISEASE, OPERATED WITH HYPOTHERMIC AND NORMOTHERMIC CARDIOPULMONARY BYPASS
by: D. G. Shakhin, et al.
Published: (2017-12-01)

Right ventricular dysfunction for prediction of long‐term recovery in de novo HFrEF : a PROLONG‐II substudy
by: Aiste Monika Jakstaite, et al.
Published: (2025-06-01)

N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN DIAGNOSTICS OF NON-COMPACTED MYOCARDIUM IN CHILDREN
by: E. N. Arkhipova, et al.
Published: (2012-10-01)

Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy
by: I. G. Kirillova, et al.
Published: (2020-03-01)

PARALLELS BETWEEN THE HEMODYNAMIC PROFILE AND BIOMARKERS ACTIVITY IN DIFFERENT FORMS OF ACUTE HEART FAILURE IN THE EARLY PERIOD AFTER AORTOCORONARY BYPASS
by: D. A. Laletin, et al.
Published: (2017-11-01)

N-terminal pro-brain natriuretic peptide as a predictive marker of short-term mortality in sepsis
by: Amit Kumar, et al.
Published: (2025-04-01)

NT-proBNP for Heart Failure Screening in Primary Care in an Eastern European Country: What We Know and Proposed Steps
by: Ioana Camelia Teleanu, et al.
Published: (2025-01-01)

Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infection
by: N. M. Kalashnikova, et al.
Published: (2023-07-01)

Prevalence of heart failure among hospitalized patient with T2D: results of a prospective observational multicenter study (CREDO)
by: M. B. Antsiferov, et al.
Published: (2024-03-01)

Comparative effectiveness of spirapril and enalapril in patients with coronary heart disease-caused chronic heart failure
by: S, Yu. Volkova, et al.
Published: (2006-08-01)

Laboratory predictors of clinical outcomes in patients with atrial fibrillation
by: A. A. Sokolova, et al.
Published: (2021-05-01)

Relationship between Mildly Elevated NT-proBNP Levels and Heart Failure Stages in the Elderly
by: Rana A. Hallak, et al.
Published: (2024-10-01)

Prognostic significance of the biomarker NT-proBNP in the surgical treatment of aortic stenosis (pilot study)
by: I. A. Kozlov, et al.
Published: (2023-06-01)

Diagnostic value of N-terminal pro-B-type natriuretic peptide in hemodialysis patients
by: D. S. Sedov, et al.
Published: (2020-02-01)

Renal venous Doppler ultrasound – a new parameter for predicting outcomes in patients with decompensated heart failure
by: Zh. D. Kobalava, et al.
Published: (2023-07-01)

Changes of NT-proBNP and sST2 levels for predicting isolated episodes of ventricular tachyarrhythmias and electrical storm in patients with systolic heart failure and various implanted devices
by: A. Zh. Gasparyan, et al.
Published: (2020-12-01)

RELATION OF THE MARKERS OF MYOCARDIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION WITH STRUCTURAL AND FUNCTIONAL PARAMETERS OF THE LUNGS IN MYOCARDIAL INFARCTION PATIENTS
by: O. M. Polikutina, et al.
Published: (2018-04-01)

Systemic ATTR-amyloidosis, a Rare Form of Internal Organ Damage
by: V. V. Rameev, et al.
Published: (2019-07-01)

New opportunities for preclinical diagnostics of antitumor therapy cardiotoxicity: results of an observational study
by: Yu. A. Vasyuk, et al.
Published: (2025-08-01)

Diagnostic, prognostic and therapeutic potential of 6-minute walk test in patients with heart failure
by: A. V. Budnevsky, et al.
Published: (2020-12-01)

Potential of NT-proBNP and sST2 rapid tests in patients with acute myocardial infarction
by: V. V. Ryabov, et al.
Published: (2023-07-01)

Speckle-tracking echocardiography in the early diagnosis of heart failure after ST-segment elevation myocardial infarction
by: V. E. Oleinikov, et al.
Published: (2021-02-01)

Assessment of the Level of NT-proBNP in Patients with Arterial Hypertension Aged 80 Years and Older, Depending on the Presence of Heart Failure and Senile Asthenia Syndrome
by: V A. Safronenko, et al.
Published: (2024-10-01)

Bedside ultrasound assessment of venous congestion by VExUS protocol in heart failure: clinical associations and prognostic value
by: Zh. D. Kobalava, et al.
Published: (2023-10-01)

Three-dimensional (3D) vs. conventional echo evaluation of ventricular function in patients with sepsis or septic shock: a prognostic value
by: Abdelrahman K. Mohamed, et al.
Published: (2025-08-01)

Circulative biomarkers as predictors of cardiovascular events in patients after treatment of Hodgkin lymphoma
by: B. B. Samura
Published: (2017-12-01)

Frailty determinants in heart failure: Inflammatory markers, cognitive impairment and psychosocial interaction
by: Marta Wleklik, et al.
Published: (2025-06-01)

Biomarkers of hemodynamic status in patients with moderate and severe COVID-19
by: Yu. K. Shapovalov
Published: (2022-12-01)

Predictive markers of atrial fibrillation in patients after acute ST-elevated myocardial infarction (the results of observational program “FAKEL”)
by: I. A. Zolotovskaya, et al.
Published: (2018-10-01)

Hydration status in patients hospitalized with acute decompensated heart failure depending on the severity of glucose metabolism disorder
by: V. V. Tolkacheva, et al.
Published: (2024-01-01)

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)

Diagnostic value of cardiac marker concentrations in patients with heart failure depending on frailty syndrome
by: V. A. Safronenko, et al.
Published: (2024-10-01)